Washington, DC - The United States Supreme Court is now at the forefront of deliberations concerning the accountability of Purdue Pharma, the manufacturer of OxyContin, and its alleged role in the nationwide opioid crisis. The High Court convened to address a challenge brought forth by the Justice Department against last year's six-billion-dollar settlement reached by Purdue Pharma.
The settlement, approved in a bankruptcy ruling by a New York court, has been a subject of contention as it provided a shield for the Sackler family, who controlled Purdue Pharma, from future litigation. The Sacklers, previously synonymous with. . .